loading
Olema Pharmaceuticals Inc stock is traded at $5.115, with a volume of 237.64K. It is down -0.78% in the last 24 hours and up +2.20% over the past month. Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
See More
Previous Close:
$5.16
Open:
$5.08
24h Volume:
237.64K
Relative Volume:
0.27
Market Cap:
$349.97M
Revenue:
-
Net Income/Loss:
$-96.66M
P/E Ratio:
-2.3791
EPS:
-2.15
Net Cash Flow:
$-83.73M
1W Performance:
+8.70%
1M Performance:
+2.20%
6M Performance:
-41.69%
1Y Performance:
-41.35%
1-Day Range:
Value
$4.98
$5.18
1-Week Range:
Value
$4.51
$5.19
52-Week Range:
Value
$2.86
$16.62

Olema Pharmaceuticals Inc Stock (OLMA) Company Profile

Name
Name
Olema Pharmaceuticals Inc
Name
Phone
(415) 651-3316
Name
Address
780 BRANNAN STREET, SAN FRANCISCO
Name
Employee
102
Name
Twitter
Name
Next Earnings Date
2025-03-18
Name
Latest SEC Filings
Name
OLMA's Discussions on Twitter

Compare OLMA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
OLMA
Olema Pharmaceuticals Inc
5.115 320.90M 0 -96.66M -83.73M -2.15
Biotechnology icon
ONC
Beigene Ltd Adr
241.12 24.41B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
435.55 111.55B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.335 42.47M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
588.39 63.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
74.97 5.92B 0 -153.72M -103.81M -2.00

Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-02-24 Initiated Goldman Buy
Jan-30-24 Initiated Citigroup Buy
Jul-21-23 Initiated Oppenheimer Outperform
May-05-23 Initiated CapitalOne Overweight
Feb-22-23 Initiated Credit Suisse Outperform
Jul-06-22 Resumed Canaccord Genuity Buy
Jun-09-22 Upgrade H.C. Wainwright Neutral → Buy
Feb-28-22 Initiated H.C. Wainwright Neutral
Dec-07-21 Resumed Cowen Outperform
Dec-14-20 Initiated Canaccord Genuity Buy
Dec-14-20 Initiated Cowen Outperform
Dec-14-20 Initiated JP Morgan Overweight
Dec-14-20 Initiated Jefferies Buy
View All

Olema Pharmaceuticals Inc Stock (OLMA) Latest News

pulisher
04:51 AM

BNP Paribas Financial Markets Makes New $1.13 Million Investment in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

04:51 AM
pulisher
May 22, 2025

Wall Street Analysts See a 386.42% Upside in Olema Pharmaceuticals (OLMA): Can the Stock Really Move This High? - MSN

May 22, 2025
pulisher
May 21, 2025

Olema Oncology Advances Cancer Trials with Strong Financials - TipRanks

May 21, 2025
pulisher
May 21, 2025

Olema Oncology to Participate in Upcoming Investor Conferences | - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Olema Oncology to Participate in Upcoming Investor Conferences | OLMA Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Olema Oncology to Participate in Upcoming Investor Conferences - GlobeNewswire

May 21, 2025
pulisher
May 21, 2025

Breast Cancer Biotech Olema Sets Major Presentations at Goldman Sachs and Jefferies Healthcare Conferences - Stock Titan

May 21, 2025
pulisher
May 19, 2025

Paradigm Biocapital Advisors LP Purchases 1,801,370 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

May 19, 2025
pulisher
May 19, 2025

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Bought by MPM Bioimpact LLC - MarketBeat

May 19, 2025
pulisher
May 18, 2025

Price T Rowe Associates Inc. MD Has $153,000 Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

May 18, 2025
pulisher
May 17, 2025

The Goldman Sachs Group Cuts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $18.00 - Defense World

May 17, 2025
pulisher
May 17, 2025

Oppenheimer Cuts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $22.00 - Defense World

May 17, 2025
pulisher
May 17, 2025

Q2 EPS Estimate for Olema Pharmaceuticals Raised by Analyst - Defense World

May 17, 2025
pulisher
May 16, 2025

Voya Investment Management LLC Cuts Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

May 16, 2025
pulisher
May 16, 2025

Driehaus Capital Management LLC Takes $1.28 Million Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

May 16, 2025
pulisher
May 15, 2025

Analysts Offer Insights on Healthcare Companies: Astria Therapeutics (ATXS), Aquestive Therapeutics (AQST) and Olema Pharmaceuticals (OLMA) - The Globe and Mail

May 15, 2025
pulisher
May 15, 2025

Companies Like Olema Pharmaceuticals (NASDAQ:OLMA) Are In A Position To Invest In Growth - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Olema Pharmaceuticals (OLMA) Price Target Lowered by Oppenheimer - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Balyasny Asset Management L.P. Increases Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

May 15, 2025
pulisher
May 14, 2025

Olema Pharmaceuticals (OLMA) Price Target Lowered by Goldman Sachs | OLMA Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Olema Oncology (OLMA) Price Target Adjusted Amid Upcoming Data R - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Lightspeed Management Company L.L.C. Makes New Investment in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

May 14, 2025
pulisher
May 13, 2025

Olema Oncology (OLMA) Pushes Forward with Promising Cancer Treat - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Olema Oncology (OLMA) Pushes Forward with Promising Cancer Treatments | OLMA Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Olema Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 13, 2025
pulisher
May 13, 2025

Olema Oncology Reports First Quarter 2025 Financial and Operating Results - The Manila Times

May 13, 2025
pulisher
May 13, 2025

Olema Oncology Strengthens Breast Cancer Pipeline: Key Phase 3 Trial Updates and $392M War Chest - Stock Titan

May 13, 2025
pulisher
May 13, 2025

Hsbc Holdings PLC Invests $58,000 in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

May 13, 2025
pulisher
May 12, 2025

Olema Pharmaceuticals (OLMA) Projected to Post Earnings on Wednesday - MarketBeat

May 12, 2025
pulisher
May 12, 2025

Deep Track Capital LP Decreases Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

May 12, 2025
pulisher
May 12, 2025

Dimensional Fund Advisors LP Cuts Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

May 12, 2025
pulisher
May 11, 2025

Wells Fargo & Company MN Raises Stake in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

May 11, 2025
pulisher
May 09, 2025

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Sold by BVF Inc. IL - MarketBeat

May 09, 2025
pulisher
May 08, 2025

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Purchased by Barclays PLC - Defense World

May 08, 2025
pulisher
May 07, 2025

Boxer Capital Management LLC Takes Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

May 07, 2025
pulisher
May 07, 2025

Market Insight: Olema Pharmaceuticals Inc (OLMA)’s Notable Drop, Closing at 4.60 - DWinneX

May 07, 2025
pulisher
May 07, 2025

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Acquired by Renaissance Technologies LLC - MarketBeat

May 07, 2025
pulisher
May 03, 2025

HC Wainwright Reaffirms Buy Rating for Olema Pharmaceuticals (NASDAQ:OLMA) - MarketBeat

May 03, 2025

Olema Pharmaceuticals Inc Stock (OLMA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$1.16
price down icon 17.27%
$31.18
price down icon 3.94%
$578.71
price down icon 0.54%
$286.89
price down icon 0.52%
$4.10
price down icon 2.24%
$72.94
price down icon 0.11%
Cap:     |  Volume (24h):